Gastrointestinal stromal tumors (GISTs) are growths that form in the digestive tract. The overall GIST survival rate for 5 years is 85%. However, this rate cannot predict the survival of any ...

Confirming a KIT mutation and assessing disease spread are critical initial steps for GIST management. Understanding the mutational profile helps tailor treatment, as some mutations may resist Gleevec ...

GISTs are rare tumors originating from the GI tract's supporting structures, often discovered incidentally during endoscopies. They are driven by specific genetic mutations, which influence tumor ...

GIST stands for gastrointestinal stromal tumor. When tumors spread from the gastrointestinal (GI) tract to distant tissues or organs, it is called a metastatic GIST. Newer therapies, such as imatinib ...

When you hear stomach cancer, you may assume that all tumours in the stomach behave the same way. However, it is not true. Gastrointestinal stromal tumours, or GISTs, are a rare and distinct type of ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...

Mixed liposarcoma: A study of socioeconomic and demographic factors. 5-year overall survival rates by time period and stage for GIST and STS.